AbbVie Inc. (ABBV34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 89.55 |
|---|---|
| 52-week range | 58.81 – 91.58 |
| Return, 1 month / 3 months | +4.3% / +10.1% |
| Return, 1 year / 3 years | +18.1% / +112.0% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 38.7% |
| Worst drawdown (1 year) | -22.1% |
| Average daily value traded | 0.10M BRL |
| Dividend yield | 6.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AbbVie is a biopharmaceutical company that develops and markets prescription medicines. Its portfolio spans immunology, oncology, neuroscience and eye care, along with products from its Allergan aesthetics business. The company serves patients and healthcare providers through hospitals, clinics and pharmacies, and it is based in North Chicago, Illinois, in the United States. Its medicines address chronic conditions such as inflammatory diseases, certain cancers and neurological disorders.
AbbVie Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code ABBV34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AbbVie Inc. (ABBV34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 89.55 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 182 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 18.1% and over the last three months it rose 10.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.0% | ||
| From 52-week high | -1.6% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.1% | ||
| 6-month return | 42.4% | ||
| 12-month return, skipping the last month | 13.2% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.1% | ||
| Liquidity | 58 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.10M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 6.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | +4.3% |
| 3 months | +10.1% |
| 6 months | +42.4% |
| 1 year | +18.1% |
| 3 years | +112.0% |
| 5 years | +165.7% |
Signals
| 50-day / 200-day average | 85.18 / 75.24 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.25 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Jul 2026 | USD 0.3804 |
| 13 Apr 2026 | USD 0.3663 |
| 14 Jan 2026 | USD 0.3826 |
| 13 Oct 2025 | USD 0.3682 |
| 11 Jul 2025 | USD 0.3754 |
| 11 Apr 2025 | USD 0.3946 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.